Survival rates for idiopathic pulmonary fibrosis are worse than all solid cancers except for lung and pancreatic cancer. | ...

Aileron Therapeutics' Phase 1b trial shows LTI-03 improved biomarkers and reduced SPD levels, indicating the potential to ...

Oftentimes, the cause of lung scarring isn’t clear, so healthcare providers call it idiopathic pulmonary fibrosis, meaning ...

TCGFB, a private biotech founded by healthcare VC The Column Group, is tapping California biotech Surrozen to discover ...

(RTTNews) - Aileron Therapeutics, Inc. (ALRN), Wednesday announced positive topline data from the cohort 2 of Phase 1b study evaluating LTI-03 in patients with idiopathic pulmonary fibrosis (IPF).

Lung transplantation remains a vital option for advanced IPF, with increasing transplant numbers and evolving allocation strategies. Idiopathic pulmonary fibrosis (IPF) is characterized by a ...

Idiopathic pulmonary fibrosis (an update ... Naccache JM, Gibiot Q, Monnet I, et al. Lung cancer and interstitial lung disease: a literature review. J Thorac Dis. 2018;10(6):3829-3844.

Some of the patients may require lung transplantation. There are about 200 different conditions that are categorized under ILD. The conditions commonly considered as ILDs include various disorders ...

Insilico Medicine plans to push its computer-designed drug into pivotal clinical trials after a phase 2a study demonstrated ...

Welcome to season 2 of the Medscape InDiscussion podcast series on idiopathic ... fibrosis are old or that as we age, we are going to get pulmonary fibrosis; but there's something about the lung ...

June 11, 2024 — Chronic lung ... pulmonary disease (COPD) prevalence and outcomes between the sexes. According to a ... Researchers Identify Protein Connected to Aging and Idiopathic Pulmonary ...

Interstitial Lung Diseases Pipeline Outlook DWN12088 is an investigational therapy for idiopathic pulmonary fibrosis (IPF), ...